XML 65 R53.htm IDEA: XBRL DOCUMENT
v3.25.2

Commitments and Contingencies (Details) $ in Thousands | 1 Months Ended | 6 Months Ended |  |  |  |
--- | --- | --- | --- | --- | --- | ---
Nov. 30, 2024 USD ($) | Jan. 31, 2024 USD ($) patent | Jul. 31, 2023 patent | Jun. 30, 2023 USD ($) patent | May 31, 2023 USD ($) patent | Mar. 31, 2022 USD ($) | Nov. 30, 2021 patent | Sep. 30, 2021 patent | Oct. 31, 2020 patent | Jun. 30, 2020 patent | Mar. 31, 2020 patent lawsuit | Jan. 31, 2020 patent | Jun. 30, 2025 USD ($) | Dec. 31, 2024 USD ($) | Dec. 31, 2022 lawsuit | Feb. 28, 2022 lawsuit | May 31, 2021 lawsuit
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Accrued settlement liability |  |  |  |  |  |  |  |  |  |  |  |  | $ 40,600 | $ 12,600 |  |  |
Loss contingency, patents allegedly infringed, number | patent |  | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amount awarded to other party |  | $ 57,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total commitments |  |  |  |  |  |  |  |  |  |  |  |  | 176,713 |  |  |  |
Acquired clinical samples and data for oncology development |  |  |  |  |  |  |  |  |  |  |  |  | 14,000 |  |  |  |
Potential payments to third party vendor |  |  |  |  |  |  |  |  |  |  |  |  | 50,000 |  |  |  |
Laboratory instruments supplier |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total commitments |  |  |  |  |  |  |  |  |  |  |  |  | 23,495 |  |  |  |
Material suppliers |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total commitments |  |  |  |  |  |  |  |  |  |  |  |  | 80,831 |  |  |  |
Application service providers |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total commitments |  |  |  |  |  |  |  |  |  |  |  |  | 5,685 |  |  |  |
Cloud platform service provider |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total commitments |  |  |  |  |  |  |  |  |  |  |  |  | 27,430 |  |  |  |
Other material suppliers |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total commitments |  |  |  |  |  |  |  |  |  |  |  |  | 39,272 |  |  |  |
Clinical samples and data for oncology development |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total commitments |  |  |  |  |  |  |  |  |  |  |  |  | $ 6,000 |  |  |  |
CareDX Patent Case |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of patent litigations | lawsuit |  |  |  |  |  |  |  |  |  |  | 2 |  |  |  |  |  |
Loss contingency, patents allegedly infringed, number | patent |  |  |  |  |  |  |  | 3 |  |  | 3 |  |  |  |  |  |
Gain contingency, patents allegedly infringed, number | patent |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amount awarded to other party |  | $ 96,300 |  |  |  | $ 44,900 |  |  |  |  |  |  |  |  |  |  |
ArcherDX Case |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gain contingency, patents allegedly infringed, number | patent |  |  |  | 3 | 3 |  |  |  |  |  |  | 3 |  |  |  |  |
Amount awarded from other party |  |  |  | $ 19,350 | $ 19,350 |  |  |  |  |  |  |  |  |  |  |  |
Ravgen Patent Case |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loss contingency, patents allegedly infringed, number | patent |  |  |  |  |  |  |  |  |  | 2 |  |  |  |  |  |  |
Amount awarded to other party |  | $ 57,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Genosity Inc. Patent Case |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gain contingency, patents allegedly infringed, number | patent |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |
Inivata Patent Case |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of lawsuits | lawsuit |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 |  |
Inivitae Patent Case |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loss contingency, patents allegedly infringed, number | patent |  |  |  |  |  |  | 3 |  |  |  |  |  |  |  |  |  |
NeoGenomics Patent Case |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gain contingency, patents allegedly infringed, number | patent |  |  | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Guardant Case |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of lawsuits | lawsuit |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2
Amount awarded to other party | $ 292,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class action |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other commitments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of lawsuits | lawsuit |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 |

X
- Definition Number of patent litigations. + References No definition available. + Details
Name: | ntra_LossContingencyPatentsLitigationsNumber
Namespace Prefix: | ntra_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash outflow for clinical samples and data for oncology development. + References No definition available. + Details
Name: | ntra_PaymentsForClinicalSamplesAndDataForOncologyDevelopment
Namespace Prefix: | ntra_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of potential milestones payable to other party. + References No definition available. + Details
Name: | ntra_PotentialMilestonePaymentsToOtherParty
Namespace Prefix: | ntra_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of entity's patents that another entity has allegedly infringed. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483049/450-30-50-1 + Details
Name: | us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(25)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_LitigationReserve
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount awarded from other party in judgment or settlement of litigation. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementAmountAwardedFromOtherParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount awarded to other party in judgment or settlement of litigation. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementAmountAwardedToOtherParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of another entity's patents that the entity has allegedly infringed. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9 + Details
Name: | us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of pending claims pertaining to a loss contingency. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9 + Details
Name: | us-gaap_LossContingencyPendingClaimsNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_OtherCommitmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier. + References No definition available. + Details
Name: | us-gaap_PurchaseObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=ntra_LaboratoryInstrumentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=ntra_InventoryMaterialPurchaseCommitmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=ntra_ApplicationServiceProviderMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=ntra_CloudPlatformServiceProviderMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=ntra_OtherMaterialSupplierMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=ntra_ClinicalSamplesAndDataForOncologyDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=ntra_CaredxSPatentCaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=ntra_ArcherdxPatentCaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=ntra_RavgenPatentCaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=ntra_GenosityInc.PatentCaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=ntra_InivataPatentCaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=ntra_InivitaPatentCaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=ntra_NeoGenomicsPatentCaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=ntra_GuardantIncCaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=ntra_ClassActionLawsuitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |